Dongliang Bian
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Sequential multimodal management for recurrent pulmonary NUT carcinoma: a case report.
Journal: Frontiers in oncology
Published: March 20, 2026
Evidence of Efficacy for Neoadjuvant Immunochemotherapy in a Rare Subgroup: Two Cases of Pathological Complete Response in Locally Advanced HER2-Mutant NSCLC.
Journal: Case reports in oncology
Published: March 05, 2026
Neoadjuvant PD-1 Blockade Tislelizumab (BGB-A317) in Combination With Etoposide and Platinum-Based Chemotherapy for Limited-Disease Small Cell Lung Cancer.
Journal: MedComm
Published: December 16, 2025
Neoadjuvant Chemoimmunotherapy Followed by Surgery or Radiotherapy for Stage IIIA-B Non-Small Cell Lung Cancer With Bulky N2 Disease.
Journal: The Annals of thoracic surgery
Published: August 21, 2025
Adjuvant chemotherapy for resected stage-ia lung adenocarcinoma with micropapillary histologic pattern.
Journal: Interdisciplinary cardiovascular and thoracic surgery
Published: August 11, 2025
Efficiency and safety of sintilimab-based induction therapy in potentially resectable stage III non-small cell lung cancer (LungMate-009): an open-label, phase 2 trial.
Journal: EClinicalMedicine
Published: July 10, 2025
Multi-omics profiling unveils biological and clinical insights into pulmonary sarcomatoid carcinoma.
Multi-omics profiling unveils biological and clinical insights into pulmonary sarcomatoid carcinoma.
Journal: Cell reports. Medicine
Published: May 23, 2025
Surgery after induced anti-PD-L1 therapy and chemotherapy for stage I‒III small-cell lung cancer: a phase 2 trial (LungMate-005).
Journal: Cell discovery
Published: February 12, 2025
Palliative surgery is effective in patients with EGFR-mutant lung adenocarcinoma with pleural metastasis.
Journal: Translational lung cancer research
Published: February 08, 2025
Neoadjuvant camrelizumab plus chemotherapy or apatinib for resectable stage IIA-IIIA NSCLC: a multicenter, two-arm, phase II exploratory trial.
Journal: BMC medicine
Published: December 01, 2024
Short-term intra- and peri-tumoral spatiotemporal CT radiomics for predicting major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer.
Journal: European radiology
Published: November 09, 2024
Segmentectomy for non-peripheral and peripheral small-sized non-small-cell lung cancer.
Journal: Interdisciplinary cardiovascular and thoracic surgery
Published: October 11, 2024
Last Updated: 09/26/2026